Steve has decades of experience in the pharmaceutical industry, including Syntex, Roche (Head DMPK & Bioanalysis), Adolor (Head DMPK & Bioanalysis) and UCB Pharma (Nonclinical Head DMPK & Bioanalysis). He is an internationally-experienced Pharmaceutical Research Executive with significant experience in early discovery molecules and late stage drug development contributing to multiple NDA approvals. Built and led interdisciplinary teams through all aspects of drug discovery and development within large and small company environments. Expertise in small molecule lead optimization and ADME, biologics PK, PK/PD, modeling and simulation, GLP bioanalysis, toxicokinetics, CRO management, nonclinical operations, IND and IRB submissions. Known for creative problem solving.